Moreover, an RCT showed that daily 360 μg of MK-7 for 12 weeks in insulin-dependent patients with diabetes improved significantly fasting glucose levels, glycated hemoglobin, insulin concentrations and homeostatic model assessment for insulin resistance (HOMA-IR). This evidence concerns the gene INS and diabetes mellitus.